key: cord-0832039-3aty5gl9
authors: Guan, Bin; Frank, Karen M.; Maldonado, José O.; Beach, Margaret; Pelayo, Eileen; Warner, Blake M.; Hufnagel, Robert B.
title: Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin
date: 2021-08-09
journal: iScience
DOI: 10.1016/j.isci.2021.102960
sha: 6ffd732173ce0816cf1b564608289e80dce91fb7
doc_id: 832039
cord_uid: 3aty5gl9

Current conventional detection of SARS-CoV-2 involves collection of a patient sample with a nasopharyngeal swab, storage of the swab during transport in a viral transport medium, extraction of RNA, and quantitative reverse transcription PCR (RT-qPCR). We developed a simplified preparation method using a chelating resin, Chelex, that obviates RNA extraction during viral testing. Direct detection RT-qPCR and digital-droplet PCR was compared to the current conventional method with RNA extraction for simulated samples and patient specimens. The heat-treatment in the presence of Chelex markedly improved detection sensitivity as compared to heat alone, and lack of RNA extraction shortens the overall diagnostic workflow. Furthermore, the initial sample heating step inactivates SARS-CoV-2 infectivity, thus improving workflow safety. This fast RNA preparation and detection method is versatile for a variety of samples, safe for testing personnel, and suitable for standard clinical collection and testing on high throughput platforms.

Diagnostic testing for SARS-CoV-2 is crucial to combatting the current COVID-19 pandemic, even as Rosenstierne, 2020). Thirdly, proteinase K and heat has been used for NP and oropharyngeal swabs with 24 91% sensitivity, albeit with higher Ct than the conventional RNA extraction method in the RT-qPCR 

J o u r n a l P r e -p r o o f 1 and heat-treatment, were able to detect 6 genome-copies per µl of SARS-CoV-2 without RNA extraction 2 (Vogels et al., 2020) . While RNA extraction-free methods are promising, they lack the sensitivity and limit 3 of detection compared to the current CDC protocol.

In this study, we aimed to improve the reported RNA extraction-free protocols to match or exceed 5 the sensitivity to that of the standard protocol with RNA-extraction using both synthetic and human 6 samples. We tested a variety of common chemicals that are used in molecular biology laboratories, and 7 tested different preparation methods to identify reagents and conditions that (i) minimize RNA 8 degradation, (ii) allow room temperature transport, heat inactivation, and storage of human samples, and 9 (iii) provide sensitive RNA detection by RT-qPCR or RT-ddPCR. We found that Chelex ® 100, a chelating 10 ion exchange resin, preserves essentially all SARS-CoV-2 RNA in the sample and permits direct 11 detection by both RT-qPCR and RT-ddPCR. We further demonstrated a COVID-19 testing workflow that 12 immediately inactivated the virus and omitted RNA-extraction while preserving the sensitivity of the 13 standard protocol with RNA-extraction. 2020; Fomsgaard and Rosenstierne, 2020), we set out to test these conditions in a direct dried swab 21 elution procedure. We simulated the dry swab procedure by desiccating the mixture of inactivated SARS-

CoV-2 virions with known genome copies and 293FT cells using a speedvac centrifuge at room 23 temperature. After resuspending the virus and cells in lowTE to a concentration of 1,000 genome 24 copies/µl, we quantified the virus with RT-ddPCR using the N1 and N2 primers and showed that only 25 J o u r n a l P r e -p r o o f ~30% of virions were detected ( Figure 1A , dried swab, no heat). Heating increased the detected virus to 1 ~40% of added virions ( Figure 1A , dried swab, heat).

As RNases are Mg 2+ -dependent similar to DNases, and Chelex polymers have been used 3 successfully for DNA preparation for its property of chelating divalent ions (Walsh et al., 1991) , we tested 4 viral RNA isolation using Chelex. Heating the sample along with 5% Chelex improved virion detection to 5 ~50% ( Figure 1A , dried swab, Heat_Chelex). We suspected that the desiccation-resuspension process 6 caused viral and cellular RNA degradation. To confirm this, we added virions and 293FT cells directly to 7 lowTE and measured viral RNA content ( Figure 1A , wet swab). Heating the sample in lowTE in the 8 presence of Chelex led to the detection of ~100% of virions added. The RPP30 mRNA also had the 9 highest yield in the presence of Chelex. Heating without Chelex led to more RPP30 mRNA degradation 10 but better detection of the SARS-CoV-2 RNA as compared to no heat condition. The N1, N2 primers 11 produced minimum background as shown in the controls (lowTE and 293FT cells suspended in lowTE)

( Figure 1B ).

The pH of 5% Chelex in water is 10-11 (Walsh et al., 1991) . Because alkaline conditions are 14 expected to lead to rapid RNA hydrolysis, we postulated that Tris pH8.0 in the lowTE buffer was critical 15 for the high detection rate of SARS-CoV-2 virions in the presence of Chelex. To test this, we measured 16 detectable virion RNA when samples were prepared in water ( Figure 1C ). In water, heating with Chelex 17 only detected 20% of added virions, and 15% of the RPP30 mRNA detected in the lowTE/Chelex 18 condition. We also simulated swab stored in MEM α media, which has a similar formulation to VTM.

Heating in MEM α led to an undetectable level of viral RNA and RPP30 mRNA, possibly due to the 1.8 20 mM Ca 2+ and 0.8 mM Mg 2+ present in the media. Inclusion of Chelex during heating resulted in detection 21 of >55% of viral RNA ( Figure 1C ). We found that inclusion of 2.5-5% DMSO in the final ddPCR reaction 22 reduced negative droplets intensity ( Figure S1 ), we also simulated swab stored in the TED10 (90% lowTE 23 + 10% DMSO) buffer, which results in 2.5% DMSO in the ddPCR reaction and thus potentially simplifies 24 reaction setup. The viral and RPP30 RNA amounts detected in the TED10 buffer in Chelex was slightly 25 higher than those in lowTE buffer.

J o u r n a l P r e -p r o o f

The CDC recommends VTM for specimens for viral culture and viral detection, which contains 1 HBSS 1X with calcium and magnesium, 2% heat-inactivated FBS, Gentamicin and Amphotericin B (CDC 2 SOP# DSR-052-05 accessed on 11/16/2020, https://www.cdc.gov/coronavirus/2019-3 ncov/downloads/Viral-Transport-Medium.pdf). The 1X HBSS buffer contains 1.3 mM Ca 2+ and 0.9 mM 4 Mg 2+ , which may lead to viral RNA degradation during heating, similar to MEM α medium. We tested the 5 HBSS buffer without Ca 2+ /Mg 2+ but supplemented with 2% heat-inactivated FBS, HBSS buffer containing 6 Ca 2+ /Mg 2+ and 2% heat-inactivated FBS, the M4 transport medium (HBSS based medium, containing 7 HEPES, BSA, gelatin, and antibiotics), and PBS in the RNA-extraction free assay ( Figure 1D ). Heat 8 increased viral detection for calcium/magnesium free media, but not the calcium/magnesium media. Only 9 ~12% of viral RNA was detected in the HBSS containing Ca 2+ /Mg 2+ and 2% heat-inactivated FBS after 10 heating, in contrast, heating in the presence of Chelex allowed the detection of 84% of virions.

In summary, LowTE pH 8.0 and TED10 with Chelex produced the highest amounts of viral RNA 12 detected as compared to no heat or heating conditions among the buffers tested.

Buffers allowing successful RT-qPCR without conventional RNA extraction 14 To investigate whether other agents besides Chelex could similarly be used for efficient RNA extraction- Next, we tested saliva samples with known added virion concentrations. Inactivated SARS-CoV-8 2 virions were also added to saliva, which were then mixed 1:1 with various buffers as above, to test 9 whether saliva samples can be subjected to direct RNA detection. Saliva samples without exogenous 10 chemicals or in DMSO were superior for RT-qPCR detection among the tested conditions ( Figure S2A ).

Chelex 5% did not improve Ct for saliva, while decreased 3.4 Ct cycles for saliva 1:1 mixed with DMSO 12 ( Figure S2A ).

We then determined the maximum concentrations of tested chemicals that were tolerated in a 14 RT-qPCR reaction ( Figure S2B ). Samples were heat-treated with Chelex and serial dilutions of 2-fold 15 were used for RT-qPCR. The highest chemical concentrations that did not interfere with RT-qPCR if using 16 5 µl of undiluted sample in a 20 µl reaction were Urea 0.5 M, DMSO 50%, EDTA 0.5 mM ( Figure S2B ).

The N1 & N2 Ct values for the undiluted sample in lowTE was the lowest, lower than RNA-extraction 18 using the same amount of virions, likely reflecting RNA loss during RNA extraction.

Together these results indicate that, by obviating the RNA extraction step, the presence of Chelex 

We attempted to further refine the buffer for this RNA-extraction free method by adjusting DMSO without Chelex lowered Ct values by more than 2 cycles compared to non-heated samples. We further 4 found that increasing Chelex levels in DMSO increased detectable viral and cellular RNA ( Figure S3B ).

To improve the limit of detection for RT-qPCR, we optimized the reaction conditions by (i) 6 including 2.5% DMSO in the final reaction if a sample does not contain DMSO, (ii) reducing the reaction 7 volume to 10 µl, (iii) using the NEB-Luna-program II for RT-qPCR, reducing denaturing time from 10 8 seconds to 5 seconds and annealing/extension time from 40 seconds to 20 seconds ( Figure S4 ). Under 9 this condition, the Ct for Non-template controls were either undetermined or above 38. When analyzing 10 the 10-fold serial dilutions of SARS-CoV-2 virions using our new preparation method by RT-qPCR, the 11 LoD was 200 copies per swab or 1000 copies/ml of samples before RT-qPCR ( Figure 2A ). Using the 12 conventional RNA extraction method, the LoD was 2,000 genome copies per swab or 667 copies/ml of 13 samples in VTM ( Figure 2A ). The LoD for saliva samples using the Chelex method was also at 1000 14 copies/ml for all replicates when 50 µl whole unstimulated saliva was added to 25 µl of 50% Chelex, 15 compared to the proteinase K method, which was undetermined for a single 1000 copies/ml replicate 16 ( Figure 2B ).

We then used RT-ddPCR to determine whether we could detect a lower virion copy number.

Because we occasionally observed 1 or 2 positive droplets in the no-template control reactions, we 19 applied 1.8 copies/µl, or 50% higher than the maximum N1/N2 mean of negative controls ( Figure 

( Figure 2C and Table 1 ). The RNA extraction method only detected 30-50% of RNA molecules at the viral 24 loads tested (Table 1) .

In summary, the lower limit of detection of the Chelex method is 1 copy/µl in NP or saliva under 26 optimized buffer conditions and it avoids virion loss as observed in RNA extraction protocols.

J o u r n a l P r e -p r o o f Patient samples 1 We then validated our Chelex RNA preparation method using primary patient samples. NP swabs were 2 collected in M4 (N=14, S01 to S14, Figure 3A ) or PBS (N=2, S15 & S16). These samples were tested in 3 the NIH Clinical Center diagnostic laboratory using conventional CDC RNA extraction and RT-qPCR 4 method (easyMAG-CL method), then frozen. Three of these samples, S01 to S03, had viral titer above 5 200 genome copies/µl. Twelve samples had viral titer less than 20 genome copies/µl, including eight 6 considered indeterminate because only one of N1 or N2 targets was positive. One sample, S14, was 7 negative.

Samples were thawed and mixed with the Chelex resin, heat-inactivated, and subjected to RT-9 qPCR using the NEB Luna RT-qPCR kit (Chelex-Luna method). As the easyMAG-CL method enriched 10 sample 4-fold before RT-qPCR, we expected that Ct values from the Chelex-Luna method would increase 11 by 2-fold including loss that may occur during RNA extraction (50% detectable viral materials in M4 in the 12 Chelex-Luna assay; Figure 1D ). The Ct values for N1, N2, and RPP30 from clinical laboratory RT-qPCR 13 and NEB Luna RT-qPCR were comparable when using a common set of purified patient RNA samples 14 with different viral titer (data not shown). The mean difference of N1 Ct between the two methods was 15 2.7, excluding four samples (S10, S11, S12, and S16) that did not show a Ct value in the Chelex-Luna 16 assay.

Of the twelve samples with less than 20 genome copies/µl, eight (or 67%) showed as positive in 18 the N1 Chelex-Luna assay, including two samples (S13 and S15) that showed lower Ct values and 19 another (S08) with the similar Ct value. The N2 Ct values were higher than N1 and many were higher 20 than 38, thus were not informative for the low titer samples in the Chelex-Luna assay. Two NP swab 21 samples stored in the CDC-suggested VTM (HBSS with Calcium & Magnesium, S17 and S18) were Figure 3B ). The mean Ct differences between the Chelex and RNA extraction methods for N1 and 1 N2 were 1.6 and 2.6 respectively. Among the six samples with less than 10 genome copies/µl as 2 determined by the RNA extraction method, five showed as positive and one (Saliva20) was indeterminate 3 in the Chelex assay ( Figure 3B ). Thus, the Chelex method demonstrated similar sensitivity as the RNA 4 extraction method for both primary NP swab and saliva samples.

We then tested the optimized Chelex RNA isolation method prospectively by collecting 

The NP sample N1 Ct differences for patients P2 to P7 between these two methods were -1.9, -2.1, -4.2, 17 0.8, -3.2, and -6.4, and their N2 Ct differences were -0.3, -5.5, -6.1, -0.7, -3.2, and -9.7. The saliva 18 samples' N1 Ct differences for patients P4 to P7 between these two methods were -1.1, -2.1, -2.5, and -19 1.1, and their N2 Ct differences were -5.6, -3.9, -3.7, and -7.2. Thus, the Chelex method may offer better 20 sensitivities using the procedure here. In addition, the Chelex method allowed sample processing without 21 a Biosafety Cabinet hood as the samples were inactivated before tube opening.

Sample stability at room temperature 23 We then determined whether viral and cellular RNA were stable over time. Samples were stored at room 24 temperature then heat-treated in the presence of Chelex and assayed at different timepoints as indicated 25 ( Figure 4 ). Viral RNAs in lowTE or TED10 were relatively stable at room temperature and ~80% of N1 or 26 N2 RNAs were detected on day 5 ( Figure 4A ). Viral RNAs were less stable in MEM α medium as > 80% 27 J o u r n a l P r e -p r o o f were degraded after 3 days ( Figure 4A ). The cellular RNA was less stable than viral RNA in the similar 1 conditions ( Figure 4A ). We then determined the RNA stability at room temperature after heat-treatment 2 with Chelex ( Figure 4B ). Heat-treatment stabilized both viral and cellular RNA, and >80% viral RNAs 3 and >60% cellular RNA were detected on day 5 ( Figure 4B ).

A similar stability experiment was performed for virions prepared in saliva samples. The viral 5 RNAs were stable in saliva before heat-treatment, as a higher amount of viral RNAs were detected after 6 storage at room temperature, possibly because interfering agents in saliva degrade during storage 7 ( Figure 5A ). However, the viral RNA stability decreased markedly after heat treatment ( Figure 5B ). 

Our preparation approach using Chelex polymer increased RNA yield available for RT-qPCR and

RT-ddPCR detection compared to the conventional method using the simulated samples with the ATCC 12 SARS-CoV-2 virions. When using stored patient samples, RNA extraction provided higher sensitivity 13 ( Figure 3A , B). This is likely due to the enrichment arising from the lower volume of RNA eluate as 14 compared to the input sample volume. The lower sensitivity of the Chelex method seen in Figure 3A 15 could be also due to RNA loss during the freeze-thaw cycle. When the samples were tested side-by-side 16 ( Figure 3B ), the sensitivities of the Chelex method and RNA extraction method are comparable. When 17 patient samples were collected in VTM (S17 & S18 in Figure 3A ), the N1 and N2 Ct values increased 2 18 and 4, respectively, suggesting that the Chelex method on VTM-collected samples may result in lower 19 sensitivity for some low viral load samples. Further, we found that N1 and N2 responded differently 20 toward components in the VTM as the N1 Ct increased while N2 Ct decreased after 1:2 dilution (S19 & 21 S20 in Figure 3A ). Our results in Figure 3C showed that collecting the swab directly in Chelex-TED 22 (TE+DMSO) buffers followed by heating provided the best sensitivity for SARS-CoV-2 detection. The

higher LoD associated with conventional RNA extraction method was due to dilution in the VTM and loss 24 of RNA during RNA extraction as shown in Table 1 . In addition, viral RNA may be degraded faster when 25 storing in the calcium/magnesium containing VTM, as suggested by data presented in Figure 4A . As 26 J o u r n a l P r e -p r o o f such, we recommend primary sample collection for this RNA isolation method in either TED or lowTE 1 buffer, which has similar or better detection performance as RNA extraction methods for primary samples 2 collected in VTM.

We also demonstrate that the Chelex method allows for highly-reproducible detection of 1 4 genome copy/µl of the SARS-CoV-2 virions, a 6-15-fold improvement in detection sensitivity (Mancini et 

We selected a temperature above 95 °C for heat inactivation for two reasons, one was that a 16 much shorter duration is required to inactive RNA viruses at higher temperatures. Secondly, heat-17 inactivation at 60 °C for 60 minutes was shown to decrease the 50% tissue culture infectivity dose more Thus, the Chelex method will save cost and reduce supply chain burden by eliminating the need for RNA 3 extraction and VTM. The Chelex-based RNA preparation method, amenable for high-throughput 4 processing, is expected to shorten diagnostic testing time by omitting the RNA extraction step and 5 omitting the chemical disinfection of patient samples. This method utilizes a heat-inactivation step that 6 minimizes viral RNA loss and inactivates virus prior to tube opening, therebylimiting exposure of 7 laboratory personnel to live virus. Therefore, we fully expect that this method will facilitate broader 8 availability and testing capacity for not only, COVID-19, but also for other infectious pathogens. Because 

Because the Chelex method also allowed cellular RNA detection, we expect that the method 

In summary, we robustly demonstrate improvements in COVID-19 viral testing workflow using Bio-Rad, the low limit of detection in the 1-well RT-ddPCR assay system is 2 positive droplets and no 10 positive droplets observed in no-template controls. Thus, the low limit of detection in a RT-ddPCR assay 11 could reach 100 copies/ml if performing in a clean room. Another limitation of the current study is that the 12 ATCC heat-inactivated virions were used in the method development and room temperature stability 13 assays. Because the heat-inactivation process may alter virion structure and/or RNA structure, the ATCC 

(A) Patient NP swab samples were heated in the presence of 5% Chelex (S01 to S16, and S19, S20) or 20 10% Chelex (S17 & S18). S19 & S20 are 1:2 dilution of S17 & S18 in LowTE, respectively. 

Chelex was first prepared in H2O, lowTE, or TED99 at 50% (50 grams/100 ml total volume, or 14 500 milligrams Chelex to 550 µl H2O). The 50% Chelex was then added in 1/10 volume to samples to 15 obtain 5% Chelex in a PCR strip with a wide-bore tip. The samples were vortexed briefly then heated in a 16 PCR cycler for 5 min at 98 °C, followed by spinning at 1,000 to 2,000xg for 2 mins in a swing-rotor. The 17 supernatant was then used for RT-qPCR or -ddPCR.

For simulated samples involving the ATCC virions, the RNeasy mini kit (Qiagen) was used to 19 extract RNA from virion and cell mixture of less than 10 µl that contained the expected amounts of virions. 

The 1-Step RT-ddPCR Advanced Kit for Probes (#186-4021, Bio-Rad) was used for RT-ddPCR 17 using the QX200 Droplet Digital PCR System (Bio-Rad). The cycling condition for RT-ddPCR was: 50°C 18 for 60 min, 95°C for 10 min, and 40 cycles of 94°C for 10 sec and 55°C for 60 sec, followed by 98°C for 19 10 min, 4°C for 30 min then hold at 4°C. If DMSO was not present in the sample, DMSO was added to 20 2.5% in the RT-qPCR or -ddPCR reaction, unless specified otherwise. Copies/µl c R P P 3 0 R P P 3 0 c R P P 3 0 R P P 3 0 c R P P 3 0 R P P 3 0 c R P P 3 0 R P P 3 0 S09 S10 S11 S12 S13 S14 S15 S16 S17 S18 S19 S20 S09 S10 S11 S12 S13 S14 S15 S16 S17 S18 S19 S20 S01 S02 S03 S04 S05 S06 S07 S08 S09 S10 S11 S12 S13 S14 S15 S16 S17 S18 S19 S20 P1  P2  P3  P4  P5  P6  P7  P1  P2  P3  P4  P5  P6  P7  P1  P2  P3  P4  P5  P6  P7  P1  P2  P3  P4  P5  P6  P7   12 

Fast 3 SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples

Urea as the only inactivator of RNase for 6 extraction of total RNA from plant and animal tissues

Pooled Saliva Specimens for SARS-CoV-2 Testing

SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction. 13 bioRxiv

Direct RT-qPCR detection of SARS-CoV-2 RNA from patient 16 nasopharyngeal swabs without an RNA extraction step

A rapid and cost-19 efficient DMSO-based method for isolating DNA from cultured lichen photobionts

Evaluation of simple 21 nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens 22 during global shortage of extraction kits

An alternative workflow for molecular detection of 24 SARS-CoV-2 -escape from the NA extraction kit-shortage

CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic

Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal 31 specimens without extraction of viral RNA

SARS-CoV-2 infection of the oral cavity and saliva

SHERLOCK: nucleic 1 acid detection with CRISPR nucleases

Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials

Pre-treatment of the clinical sample with Proteinase K 7 allows detection of SARS-CoV-2 in the absence of RNA extraction

Laboratory management for SARS-CoV-2 detection: a user-10 friendly combination of the heat treatment approach and rt-Real-time PCR testing

SARS-CoV-2 detection by direct rRT-PCR without RNA extraction

Influence of Organic Aqueous-Media in the 16

Rnase Activity of Spleen Phosphodiesterase

Validation of Common Housekeeping 19 Genes as Reference for qPCR Gene Expression Analysis During iPS Reprogramming Process

Development of 22 Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute 23 Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Heat Inactivation of 26

Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and 27 Serological Diagnostics? Viruses

Comparative evaluation of nasopharyngeal swab and saliva 30 specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19

Massive and rapid COVID-19 testing is feasible 34 by extraction-free SARS-CoV-2 RT-PCR

Preliminary support for a "dry swab, extraction free" protocol for 2 SARS-CoV-2 testing via RT-qPCR. bioRxiv

RNase H-assisted RNA-primed rolling circle amplification for targeted RNA sequence 5 detection

SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 8 testing capacity

Chelex 100 as a medium for simple extraction of DNA 10 for PCR-based typing from forensic material

Saliva or Nasopharyngeal Swab Specimens for 13 Detection of SARS-CoV-2